NASA shifts Artemis from Gateway toward lunar-base plan
NASA has outlined a phased South Pole Moon Base strategy, a pause for Gateway in its current form and a push for more commercial lunar missions.
Welcome to the Science & Health News Article page, where curiosity meets discovery. This section is dedicated to exploring the breakthroughs, research, and insights shaping our understanding of the world and our well-being.
From medical advancements and public health updates to environmental studies and space exploration, our coverage brings you knowledge from across the scientific spectrum. Whether it’s new treatments, climate research, or innovations in biotechnology, you’ll find articles that combine expert analysis with accessible insights.
We aim to inform, educate, and inspire by highlighting the discoveries that improve lives, protect our planet, and expand human knowledge. Here, science and health come together to provide a clearer view of the challenges and opportunities facing humanity.
NASA has outlined a phased South Pole Moon Base strategy, a pause for Gateway in its current form and a push for more commercial lunar missions.
HHS and ARPA-H have introduced four connected programs aimed at redesigning clinical-trial analysis, site activation, consent and patient data tools.
U.S. flu season is opening against a changed legal backdrop for the millions of workers who will call in sick over the coming months. Two of the country’s…
A randomized phase III trial found that stereotactic radiosurgery given over three to five sessions improved one-year control at the surgical site after removal of large brain metastases,…
The FDA has approved Juvmo, an oral tavapadon treatment for adults with Parkinson’s disease, following three pivotal phase 3 studies.
SpaceX planned to send Starship toward Earth orbit from Starbase, Texas, in a test that could include six orbits and deployment of 26 Starlink satellites.
Moderna has vaccinated the first participants in a Canadian Phase 1 study of mRNA-1469, an investigational vaccine against Bundibugyo ebolavirus.
Vitruvias Therapeutics has recalled one nationwide-distributed lot of Thyroid Tablets, USP 30 mg because testing found potential superpotency, which can expose patients to more thyroid hormone than intended.
A claims-data study of 2,031 U.S. patients ages 10 to 17 found that 16.8% received a nutrition-related diagnosis or complication within a year of starting a GLP-1 drug,…
Coastal flood warnings and advisories are in effect across parts of the Mid-Atlantic as high tides, onshore winds and dangerous surf threaten low-lying shoreline areas.